Adicet Bio Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.1% | +7.2% | +2.1% | -98.5% | -87.8% | +1,699.3% | -45.7% | +156.8% | -100.0% | – | – | |
| – | -1.5% | +4.1% | -100.0% | +1,500.0% | +56.3% | – | – | – | +21.7% | +6.1% | -1.3% | |
| – | +16.7% | +18.1% | +312.4% | -98.5% | -87.7% | +1,699.3% | -45.7% | +156.8% | -124.4% | – | – | |
| – | +84.3% | +13.8% | +183.4% | -12.6% | +61.0% | +44.9% | +42.5% | +45.6% | +48.8% | -6.3% | -0.2% | |
| – | +6.9% | +12.2% | +5.0% | -89.0% | +3.1% | +161.8% | -2.4% | +18.3% | +0.9% | +6.6% | -18.8% | |
| – | +10.3% | -100.0% | +1,887,600.0% | +22.6% | +39.9% | +76.3% | +24.6% | +37.1% | +55.9% | -16.1% | -9.3% | |
| – | +28.6% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | -1.0% | +88.3% | +77.0% | – | – | – | +31.3% | -54.5% | -68.8% | -84.0% | +800.0% | |
| – | +29.3% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +28.2% | +30.0% | -6.3% | -103.1% | – | -14,915.8% | – | – | – | – | – | |
| – | +29.9% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +25.8% | -100.0% | – | – | – | – | – | – | – | – | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.